One possible explanation might be that the metabolic changes elicited by mutant p53 are not mutually regulated and unidirectionally controlled in all cancer cells and may differ during the different stages of cancer progression, such as with the capacity to undergo EMT (16, 113, 137). This evidence concerns the gene TP53 and cancer.